Videla-Richardson, G.A.; Morris-Hanon, O.; Torres, N.I.; Esquivel, M.I.; Vera, M.B.; Ripari, L.B.; Croci, D.O.; Sevlever, G.E.; Rabinovich, G.A.
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. Int. J. Mol. Sci. 2022, 23, 316.
https://doi.org/10.3390/ijms23010316
AMA Style
Videla-Richardson GA, Morris-Hanon O, Torres NI, Esquivel MI, Vera MB, Ripari LB, Croci DO, Sevlever GE, Rabinovich GA.
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. International Journal of Molecular Sciences. 2022; 23(1):316.
https://doi.org/10.3390/ijms23010316
Chicago/Turabian Style
Videla-Richardson, Guillermo A., Olivia Morris-Hanon, Nicolás I. Torres, Myrian I. Esquivel, Mariana B. Vera, Luisina B. Ripari, Diego O. Croci, Gustavo E. Sevlever, and Gabriel A. Rabinovich.
2022. "Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma" International Journal of Molecular Sciences 23, no. 1: 316.
https://doi.org/10.3390/ijms23010316
APA Style
Videla-Richardson, G. A., Morris-Hanon, O., Torres, N. I., Esquivel, M. I., Vera, M. B., Ripari, L. B., Croci, D. O., Sevlever, G. E., & Rabinovich, G. A.
(2022). Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. International Journal of Molecular Sciences, 23(1), 316.
https://doi.org/10.3390/ijms23010316
